Bullous Pemphigoid

Currently Enrolling

• Regeneron protocol R668-BP-1902: A multi-center, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in adult patients with bullous pemphigoid.  |  Learn More »  |  Sign Up for This Study »

View Other Clinical Trials

• Acne
• Actinic Keratoses
• Atopic Dermatitis (Eczema)
• Axillary Hyperhidrosis
• Bullous Pemphigoid
• Hidradenitis Suppurativa
• Lamellar Ichthyosis
• Psoriasis
• Prurigo Nodularis